Collaboration with Texas Biomed, SwRI and UT Health San Antonio targets Bladder Cancer

The San Antonio Medical Foundation (SAMF) has awarded Texas Biomedical Research Institute Professor Jordi B. Torrelles, Ph.D., with a $173,000 grant to study a modified Mycobacterium bovis Bacillus Calmette et Guérin (BCG) vaccine shown to have promise for treating bladder cancer. BCG is a weakened strain of Mycobacterium bovis, a vaccine for tuberculosis.

Read more

New Patient Resource from NCCN Helps People with Bladder Cancer Make Informed Treatment Decisions

New NCCN Guidelines for Patients: Bladder Cancer explains the lengthy surveillance process that follows active treatment for the sixth most-common

Read more